Is there really an accelerated phase of chronic myeloid leukaemia?
- PMID: 38918562
- PMCID: PMC11436383
- DOI: 10.1038/s41375-024-02316-5
Is there really an accelerated phase of chronic myeloid leukaemia?
Conflict of interest statement
RPG is a consultant to Antengene Biotech LLC; Medical Director, FFF Enterprises Inc.; Speaker for Janssen Pharma and Hengrui Pharma; Board of Directors: Russian Foundation for Cancer Research Support; and Scientific Advisory Board: StemRad Ltd. JFA Advisory Boards Novartis, Terns, Ascentage; Speaker: Novartis, Incyte, Paladin. Research funding: Pfier, Incyte. AH received research support by Novartis, BMS, Incyte, Pfizer and Enliven Pharma. RPG and AH are Editors-in-Chief of
References
-
- Berman E, Shah NP, Deninger M, Altman JK, Amaya M, Begna K, et al. and the WHO: Why? J Clin Oncol. 2024;42:984–6. - PubMed
-
- Shah NP, Bhatia R, Altman JK, Amaya M, Begna KH, Berman E, et al. Chronic Myeloid Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2024;22:43–69. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical